Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
about
Clostridium difficile: its disease and toxinsEffects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro.An update on antibody-based immunotherapies for Clostridium difficile infectionClostridium difficile infection: molecular pathogenesis and novel therapeuticsNeutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domainThe analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains.An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivoPrimary human colonic myofibroblasts are resistant to Clostridium difficile toxin A-induced, but not toxin B-induced, cell death.Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB.Toxin-specific antibodies for the treatment of Clostridium difficile: current status and future perspectives.Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal diseaseDefining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile InfectionsNucleotide sequence of Clostridium difficile toxin B gene.Protection against Clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies.Clostridium difficile: clinical disease and diagnosisLocalization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A.Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and YCharacterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin).Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice.Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.Variations in virulence and molecular biology among emerging strains of Clostridium difficile.Antibodies for treatment of Clostridium difficile infection.Immune-based treatment and prevention of Clostridium difficile infection.Recombinant Mucin-Type Fusion Proteins with a Galα1,3Gal Substitution as Clostridium difficile Toxin A Inhibitors.New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunizationNonspecific binding of Clostridium difficile toxin A to murine immunoglobulins occurs via the fab component.Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples.Neutralization of Clostridium difficile toxin A using antibody combinations.Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.Effect of Clostridium difficile enterotoxin A on ultrastructure of Chinese hamster ovary cells.Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes.The role of toxins in Clostridium difficile infection.
P2860
Q24617347-25E4B299-6461-4221-9FE9-6F62ECDBB039Q24651060-D8F99DF4-9535-4703-B6C9-6B151BA2A7C5Q26740788-C2720D30-F962-4F54-88A8-0FAD087CA667Q26864237-D44D2208-E5BB-4D85-875C-E51E9E42750AQ28302768-E9A6CB08-6EA8-402E-9420-F38DEA8AC380Q30475404-80F6172E-DE33-4FB4-9DDB-92FB75606FC9Q34298763-FC597642-4B9D-4D0D-933C-EDA12FCC946CQ34740081-BABD7DF9-ACA0-443F-B767-12603923DDECQ34916871-3A1E4252-8A22-4713-8234-B53E87C7FCFCQ35155775-6CFE1ED5-870A-421D-BDBD-E70C928CD5E9Q35431790-A49713BF-08CB-4E23-88D3-24CBD850CFEFQ35676296-F9713946-030F-4D11-B24C-70BFCFBF86D4Q35849070-3B58A17B-90B3-49D5-99EA-E29DBC463093Q36379304-3A651A03-6364-4364-9A9C-6A491860AB8EQ36640296-E9C0960F-92B5-466A-B284-12E251BB8E63Q36946424-5095BF05-6919-47AA-B7BD-2FF44009D049Q36958780-3DEB0ABE-143E-4B41-AA09-F7FFA1169F4CQ36970376-ADE5A273-6A08-4552-A4C2-689D2A4E40FBQ37004400-86C12071-AC54-4124-B8B5-C16EE874EBA7Q37007343-5BE86D44-DF69-46B0-BB00-C6D142C0003DQ37122023-88805A79-FB03-4C2E-B549-DE5D7A181F82Q37258250-E330A12B-E6E6-4C57-8F52-5CF797155470Q37680481-353447CB-2F4B-4FBC-968C-7CF12F568ADFQ38208794-17B0EB43-5BF9-4367-90DE-BE9BD7B48AD6Q38350907-59CDCE70-6FAD-4EA9-9BC9-4F008DF51FBDQ38755916-DC6F31B7-89F9-4B0A-AA4F-34D8DAB54EBBQ39514376-C3196077-87A4-4D45-86A1-5D16EADD8130Q39571045-2EB073E8-3771-459D-B8D8-9F504882D967Q39663975-7A1B4B27-DED8-44E6-AB5A-2BA38B19A920Q39664838-62AEAC99-8B76-40F0-A240-CB8CA0BDFAA4Q39978401-7B293166-A517-44BC-8E54-EAD066554ABBQ40153023-DD444A82-2CAB-4F69-B2A5-8649BAE6F5ADQ40160408-70EA7AAA-A8CD-4352-BE55-45F7250547C0Q40163522-ABFD8E05-E4D7-4FCD-9427-C8B390143260Q47734724-5558A53F-69D0-4D03-ADA2-8CC6FA0DA555
P2860
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
@en
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
@nl
type
label
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
@en
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
@nl
prefLabel
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
@en
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
@nl
P2093
P2860
P1476
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
@en
P2093
P2860
P407
P577
1986-10-01T00:00:00Z